Parametric Portfolio Associates LLC raised its holdings in MEDIFAST INC (NYSE:MED) by 18.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,789 shares of the specialty retailer’s stock after acquiring an additional 6,700 shares during the quarter. Parametric Portfolio Associates LLC owned 0.37% of MEDIFAST INC worth $1,816,000 as of its most recent filing with the SEC.
A number of other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in MEDIFAST INC by 2.2% in the second quarter. Vanguard Group Inc. now owns 657,254 shares of the specialty retailer’s stock valued at $27,256,000 after acquiring an additional 13,982 shares during the period. Dimensional Fund Advisors LP lifted its holdings in MEDIFAST INC by 3.6% in the first quarter. Dimensional Fund Advisors LP now owns 632,211 shares of the specialty retailer’s stock valued at $28,051,000 after acquiring an additional 21,847 shares during the period. Kennedy Capital Management Inc. lifted its holdings in MEDIFAST INC by 4.8% in the second quarter. Kennedy Capital Management Inc. now owns 398,063 shares of the specialty retailer’s stock valued at $16,508,000 after acquiring an additional 18,183 shares during the period. American Century Companies Inc. lifted its holdings in MEDIFAST INC by 29.6% in the second quarter. American Century Companies Inc. now owns 187,230 shares of the specialty retailer’s stock valued at $7,764,000 after acquiring an additional 42,710 shares during the period. Finally, Northern Trust Corp lifted its holdings in MEDIFAST INC by 1.9% in the second quarter. Northern Trust Corp now owns 141,145 shares of the specialty retailer’s stock valued at $5,853,000 after acquiring an additional 2,597 shares during the period. 89.24% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This story was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://stocknewstimes.com/2017/11/11/medifast-inc-med-holdings-raised-by-parametric-portfolio-associates-llc.html.
MED has been the subject of a number of recent analyst reports. BidaskClub raised MEDIFAST INC from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. DA Davidson initiated coverage on MEDIFAST INC in a report on Wednesday, August 16th. They issued a “buy” rating for the company. Sidoti reissued a “neutral” rating and issued a $55.00 target price (up previously from $49.00) on shares of MEDIFAST INC in a report on Thursday, September 21st. Finally, Zacks Investment Research raised MEDIFAST INC from a “hold” rating to a “buy” rating and set a $79.00 target price for the company in a report on Friday.
MEDIFAST INC (MED) opened at $69.28 on Friday. The stock has a market capitalization of $828.32, a price-to-earnings ratio of 34.19, a PEG ratio of 2.13 and a beta of 0.45. MEDIFAST INC has a one year low of $37.67 and a one year high of $71.73.
MEDIFAST INC (NYSE:MED) last released its quarterly earnings results on Tuesday, November 7th. The specialty retailer reported $0.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.04. The business had revenue of $77.20 million during the quarter, compared to the consensus estimate of $74.94 million. MEDIFAST INC had a return on equity of 24.07% and a net margin of 8.58%. The business’s revenue was up 12.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.51 EPS. research analysts predict that MEDIFAST INC will post 2.17 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Thursday, November 9th. Stockholders of record on Friday, September 22nd were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 1.85%. The ex-dividend date was Thursday, September 21st. MEDIFAST INC’s dividend payout ratio (DPR) is presently 63.05%.
MEDIFAST INC Profile
Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.
Want to see what other hedge funds are holding MED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDIFAST INC (NYSE:MED).
Receive News & Ratings for MEDIFAST INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related companies with MarketBeat.com's FREE daily email newsletter.